Botulinum toxin type A
Botulinum toxin type A is a pharmaceutical drug with 272 clinical trials. Currently 14 active trials ongoing. Historical success rate of 91.0%.
Success Metrics
Based on 192 completed trials
Phase Distribution
Phase Distribution
27
Early Stage
68
Mid Stage
112
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.1%
192 of 218 finished
11.9%
26 ended early
14
trials recruiting
272
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults
Botulinum Toxin Type A for Frontal Hyperhidrosis
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults
Botulinum Toxin A Before Hemorrhoidectomy to Prevent Postoperative Pain
Clinical Trials (272)
Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults
Botulinum Toxin Type A for Frontal Hyperhidrosis
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults
Botulinum Toxin A Before Hemorrhoidectomy to Prevent Postoperative Pain
Botulinum Toxin-A for Hidradenitis Suppurativa
Botulinum Toxin Injection in the UES for R-CPD
Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized Study
Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids
A Dosage-dependent Manner of Botulinum Toxin Type A on the Prevention of Postoperative Scars of Various Anatomic Regions of the Body
Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine
Botox or Botox With Esophageal Dilation in Patients With Achalasia
Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine
Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy
BOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle Prominence
(Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist
Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia
An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A
Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)
A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 272